CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma

Daniel A. Belkin, Hiroshi Mitsui, Claire Q.F. Wang, Juana Gonzalez, Shali Zhang, Kejal R. Shah, Israel Coats, Mayte Suàrez-Fariñas, James G. Krueger, Diane Felsen, John A. Carucci

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


Objective: To characterize the presence of CD200 and CD200 receptor (CD200R) in the human cutaneous squamous cell carcinoma (SCC) microenvironment and to define a possible role for the CD200 axis in immune evasion by SCC. Design: Gene expression in SCC vs normal skin was studied. Laser capture microdissection was used to determine differential expression of CD200 in normal skin vs actinic keratosis vs SCC in situ vs invasive SCC. Immunofluorescence microscopy was used to define expression of CD200R on macrophages, myeloid dendritic cells, natural killer cells, and T cells in SCC vs normal skin. The effects of SCC supernatant on induction of CD200 in human blood endothelial cells was also examined. Setting: Academic Medical Center with an established Section of Mohs and Dermatologic Surgery and an active Cutaneous Biology Research Program. Participants: Surgical discard tissue from deidentified patients and samples of normal skin from healthy volunteers were used in this study. MainOutcomeMeasures: Expression ofCD200onSCCassociated blood vessels; expression of CD200 receptor on SCC-associated macrophages andTcells; and induction of CD200 on endothelial cells by SCC supernatants. Results: CD200 gene and message were upregulated in SCC stroma. Immunostaining revealed a higher number of CD200+ cells in SCC stroma than in normal dermis (180.8 cells/mm2 vs 24.6 cells/mm2) (P<.01). CD200 was further identified mainly on blood vessel endothelium in SCC. Tumor supernatant was able to induce CD200 expression on human dermal blood endothelial cells in culture. CD200R was identified on macrophages and dendritic cells in SCC microenvironment. Conclusions: CD200 expression on local blood vessels may promote tumor progression by suppressing CD200R+ myeloid cells during diapedesis. These data highlight a previously unrecognized mechanism of immune evasion by SCC and may provide guidance for the development of targeted therapy.

Original languageEnglish
Pages (from-to)178-186
Number of pages9
JournalJAMA Dermatology
Issue number2
StatePublished - Feb 2013
Externally publishedYes


Dive into the research topics of 'CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this